Evidence map›Paper›PMID 33651202›Full record

ArticleEuropean radiology2021

Vascular Ehlers-Danlos syndrome (vEDS): CT and histologic findings of pleural and lung parenchymal damage.

Samia Boussouar, Amira Benattia, Jean-Baptiste Escudié, Laure Gibault, Frédérique Capron, Anne Legrand, Pierre-Yves Brillet, Xavier Jeunemaitre, Philippe A Grenier, Elie Mousseaux and 2 more

Abstract read
PubMed Publisher
In one paragraph

Article in European radiology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. PulmonaryRespiratory medicine case reports · 2024
    Article
  9. Article
  10. Article
  11. Observational
  12. Spontaneous pneumothorax-associated with genetic disorders.Therapeutic advances in respiratory disease
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Samia BoussouarImagerie Cardiovasculaire et Thoracique (ICT), Hôpital Pitié-Salpêtrière, Assistance Publique-Hôpitaux de Paris, Paris, France, ICT Cardiovascular and Thoracic Imaging Unit, LIB Biomedical Imaging Laboratory INSERM, CNRS, ICAN Institute of Cardiometabolism and Nutrition, Sorbonne Université, Pitié-Salpêtrière Hospital (AP-HP), 47-83 Boulevard de l'hôpital, 75651, Paris CEDEX 13, France. samia.boussouar@aphp.fr.ORCID http://orcid.org/0000-0001-5489-452X
Amira BenattiaService de Pneumologie, Hôpital Saint Louis, APHP, Paris, France.
Jean-Baptiste EscudiéPôle Informatique Médicale et Santé Publique, Hôpital Avicenne, APHP, Paris, France.
Laure GibaultUniversité Paris Descartes - Service d'Anatomie Pathologique- Hôpital Européen Georges Pompidou - AP-HP, Paris, France.
Frédérique CapronSorbonne université - Service d'anatomie pathologique- Hôpital Pitié-Salpêtrière-Ch. Foix- AP-HP, Paris, France.
Anne LegrandUniversité de Paris Centre de Référence des Maladies Vasculaires Rares et service de génétique, HEGP, AP-HP et Inserm U 970, Paris, France.
Pierre-Yves BrilletUniversité Paris 13, Sorbonne Paris Cité, EA2363 'hypoxie et poumon', Paris- Service de Radiologie- Hôpital Avicenne- AP-HP-, Bobigny, France.
Xavier JeunemaitreUniversité de Paris Centre de Référence des Maladies Vasculaires Rares et service de génétique, HEGP, AP-HP et Inserm U 970, Paris, France.
Philippe A GrenierDépartement de Recherche Clinique et Innovation, Hôpital Foch, Suresnes, France.
Elie MousseauxUniversité de Paris Centre de Référence des Maladies Vasculaires Rares et service de génétique, VASCERN MSA European Reference Centre, HEGP, AP-HP et Inserm U 970, Paris, France.
Michael FrankUniversité de Paris Centre de Référence des Maladies Vasculaires Rares et service de génétique, HEGP, AP-HP et Inserm U 970, Paris, France.
Olivier SanchezUniversité de Paris - Service de Pneumologie et Soins Intensifs, Centre de Compétences Maladies Rares Pulmonaires - Hôpital Européen Georges Pompidou - AP-HP - INSERM UMRS 1140, Paris, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesTo describe CT features of lung involvement in patients with vascular Ehlers-Danlos syndrome (vEDS), a rare genetic condition caused by pathogenic variants within the COL3A1 gene, characterized by recurrent arterial, digestive, and pulmonary events. MATERIAL AND

methodsAll consecutive vEDS patients referred to the national tertiary referral center for vEDS, between 2004 and 2016, were included. Chest CT scans obtained during the initial vascular work-up were reviewed retrospectively by two chest radiologists for lung involvement. Five surgical samples underwent histologic examination.

resultsAmong 136 enrolled patients (83 women, 53 men; mean age 37 years) with molecularly confirmed vEDS, 24 (17.6%) had a history of respiratory events: 17 with pneumothorax, 4 with hemothorax, and 3 with hemoptysis that required thoracic surgery in 11. CT scans detected lung parenchymal abnormalities in 78 (57.3%) patients: emphysema (mostly centrilobular and paraseptal) in 44 (32.3%), comparable for smokers and non-smokers; clusters of calcified small pulmonary nodules in 9 (6.6%); and cavitated nodules in 4 (2.9%). Histologic examination of surgical samples found arterial abnormalities, emphysema with alveolar ruptures in 3, accompanied by diffuse hemorrhage and increased hemosiderin resorption.

conclusionIn vEDS patients, identification of lung parenchymal abnormalities is common on CT. The most frequently observed CT finding was emphysema suggesting alveolar wall rupture which might facilitate the diagnostic screening of the disease in asymptomatic carriers of a genetic COL3A1 gene mutation. The prognostic value and evolution of these parenchymal abnormalities remain to be evaluated. KEY POINTS: • Patients with vEDS can have lung parenchymal changes on top of or next to thoracal vascular abnormalities and that these changes can be present in asymptomatic cases. • The presence of these parenchymal changes is associated with a slightly higher incidence of respiratory events (although not statistically significant). • Identification of the described CT pattern by radiologists and chest physicians may facilitate diagnostic screening.

Indexed as

Ehlers-Danlos SyndromeAdultCollagen Type IIIFemaleHumansLungMaleRetrospective StudiesTomography, X-Ray ComputedCollagen Type IIICT scanEhlers–Danlos syndromeHemothoraxPneumothoraxPulmonary emphysema

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.